Showing results (121-130 of 139) with videos related to
Sort By:
Pageof 14
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|May 12, 2001
The Potential of F-18-FDG PET in Breast Cancer. Detection of Primary Lesions, Axillary Lymph Node Metastases, or Distant MetastasesK F. Hubner, G T. Smith, J A. Thie, et al.American Journal of Respiratory and Critical Care Medicine|May 6, 1999
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthmaH S Nelson, R B Berkowitz, D A Tinkelman, et al.The American Review of Respiratory Disease|February 1, 1993
A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroidsH S Nelson, D L Hamilos, P R Corsello, et al.The Journal of Allergy and Clinical Immunology|May 1, 1995
Delivery of glucocorticoids by jet nebulization: aerosol characteristics and outputJ Leflein, E Brown, M Hill, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 1999
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trialL C Borish, H S Nelson, M J Lanz, et al.Allergy|March 11, 2014
Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposureS R Durham, H S Nelson, H Nolte, et al.The Journal of Allergy and Clinical Immunology|June 9, 2001
Efficacy of soluble IL-4 receptor for the treatment of adults with asthmaL C Borish, H S Nelson, J Corren, et al.The Journal of Allergy and Clinical Immunology|October 1, 1988
Recommendations for the use of residential air-cleaning devices in the treatment of allergic respiratory diseasesH S Nelson, S R Hirsch, J L Ohman, et al.Chest|May 22, 1998
Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study GroupH S Nelson, I L Bernstein, J Fink, et al.The Journal of Allergy and Clinical Immunology|April 1, 1997
Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cellsG Lack, H S Nelson, D Amran, et al.Pageof 14